Benocyclidine-d10

Benocyclidine-d10 (BCP-d10) contains ten deuterium atoms at the 2, 2', 3, 3', 4, 4', 5, 5', 6, and 6' positions. It is intended for use as an internal standard for the quantification of BCP (Cay-11737) by GC- or LC-mass spectrometry. BCP is a derivative of phencyclidine with a benzothiophenyl group instead of a phenyl ring. It acts as a potent and selective dopamine reuptake inhibitor (IC50 = 8 nM) with negligible affinity for the NMDA receptor-linked phencyclidine receptor (K0.5 = 6 µM). BCP has been used to label the dopamine transporter in the mouse brain. This product is intended for forensic and research applications.Formal Name: 1-(1-benzo[b]thien-2-ylcyclohexyl)-2,2,3,3,4,4,5,5,6,6-d10-piperidine. Molecular Formula: C19H15D10NS. Formula Weight: 309.5. Purity: >99% deuterated forms (d1-d10). Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 5 mg/ml, Ethanol: 2 mg/ml. lambdamax: 229, 270, 300 nm. SMILES: [2H]C(C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H])([2H])N1C2(C3=CC4=C(C=CC=C4)S3)CCCCC2. InChi Code: InChI=1S/C19H25NS/c1-5-11-19(12-6-1,20-13-7-2-8-14-20)18-15-16-9-3-4-10-17(16)21-18/h3-4,9-10,15H,1-2,5-8,11-14H2/i2D2,7D2,8D2,13D2,14D2. InChi Key: RGSVXQJPSWZXOP-PGAPGPTOSA-N.